PR Newswire
DUBLIN, April 24, 2018
DUBLIN, April 24, 2018 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2018 first quarter financial results on Tuesday, May 8, 2018, after the close of the financial markets. Company management will host a live audio
webcast immediately following the announcement at 4:30 p.m. EDT/9:30 p.m.
IST to discuss first quarter 2018 financial results and provide a business and financial update.
Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at
http://www.jazzpharmaceuticals.com. Please connect
to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary
to listen to the webcast. A replay of the webcast will be archived on the website for at least one week.
Audio webcast/conference call:
U.S. Dial-In Number: +1 855 353 7924
International Dial-In Number: +1 503 343 6056
Passcode: 9868758
A replay of the conference call will be available through May 15, 2018 and accessible through
one of the following telephone numbers, using the passcode below:
Replay U.S. Dial-In Number: +1 855 859 2056
Replay International Dial-In Number: +1 404 537 3406
Passcode: 9868758
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is an international biopharmaceutical company focused on improving patients'
lives by identifying, developing and commercializing meaningful products that address unmet medical needs. The company has
a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. In these
areas, Jazz Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi),
Defitelio® (defibrotide sodium) and Vyxeos® (daunorubicin and cytarabine) liposome for injection in the U.S. and markets
Erwinase® and Defitelio® (defibrotide) in countries outside the U.S. For country-specific product information, please visit
http://www.jazzpharmaceuticals.com/products.
For more information, please visit http://www.jazzpharmaceuticals.com/ and follow us on Twitter at @JazzPharma.
Logo - https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_Logo.jpg
